U.S. market Closed. Opens in 15 hours 3 minutes

INTS | Intensity Therapeutics, Inc. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 1.8001 - 1.9800
52 Week Range 1.5000 - 7.00
Beta N/A
Implied Volatility N/A
IV Rank N/A
Day's Volume 26,506
Average Volume 27,858
Shares Outstanding 15,104,810
Market Cap 28,197,659
Sector Healthcare
Industry Biotechnology
IPO Date 2023-06-30
Valuation
Profitability
Growth
Health
P/E Ratio -1.74
Forward P/E Ratio N/A
EPS -1.07
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 5
Country USA
Website INTS
Intensity Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of cancer drugs to treat solid tumors. The company's lead product candidate is INT230-6, which is in Phase 2 clinical trial for the treatment of refractory solid tumors; and pancreatic, colon, bile duct, squamous cell carcinoma, sarcoma, breast, and liver cancers. It has a collaboration agreement with Merck Sharpe & Dohme Corp. to evaluate the combination of INT230-6 and Keytruda in patients with advanced pancreatic, colon, squamous cell, and bile duct malignancies; Bristol-Myers Squibb Company to evaluate the combination of INT230-6 with Yervoy in patients with advanced liver, breast, and sarcoma cancers; and Ottawa Hospital Research Institute and the Ontario Institute of Cancer Research to study INT230-6 in a randomized controlled neoadjuvant phase II study in women with early-stage breast cancer. The company was founded in 2012 and is headquartered in Westport, Connecticut.
*Chart delayed
Analyzing fundamentals for INTS we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see INTS Fundamentals page.

Watching at INTS technicals we can see that long-term trend is bullish, while middle-term trend is bearish, as well as bearish short-term trend. More technicals details can be found on INTS Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙